Diffuse astrocytoma, IDH-mutant
Clinical trials for Diffuse astrocytoma, IDH-mutant explained in plain language.
Never miss a new study
Get alerted when new Diffuse astrocytoma, IDH-mutant trials appear
Sign up with your email to follow new studies for Diffuse astrocytoma, IDH-mutant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on brain tumors and metastases in early trial
Disease control Recruiting nowThis study tests an oral drug called NEO212 in people with specific brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control tumor growth. About 134 adults will take NEO212 alone or with sta…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Phase 1/2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New study tests if proton radiation can spare brain tissue without hurting survival
Disease control Recruiting nowThis study compares proton therapy to standard photon radiation for people with slow-growing brain tumors (IDH-mutated gliomas). The goal is to see if proton therapy, which targets tumors more precisely, can reduce side effects and maintain quality of life without shortening surv…
Matched conditions: DIFFUSE ASTROCYTOMA, IDH-MUTANT
Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC